<i>FOXP3 Transcription Factor</i>: A Candidate Marker for Susceptibility and Prognosis in Triple Negative Breast CancerLeandra Fiori Lopes, Maria Angélica Ehara Watanabe, Roberta Losi Guembarovski et al.|BioMed Research International|2014Cited by 27
Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesisGlauco Akelinghton Freire Vitiello, Maria Angélica Ehara Watanabe, Roberta Losi Guembarovski et al.|Journal of Cancer Research and Clinical Oncology|2018Cited by 23
Glutathione S-transferases deletions may act as prognosis and therapeutic markers in breast cancerClodoaldo Zago Campos, Tânia Longo Mazzuco, Carlos Hiroji Hiroki et al.|Clinical and Experimental Medicine|2017Cited by 20
Genetic Polymorphism and Expression of CXCR4 in Breast CancerMarina Okuyama Kishima, Maria Angélica Ehara Watanabe, Karen Brajão de Oliveira et al.|Analytical Cellular Pathology|2015Cited by 18
CCR2-V64I genetic polymorphism: a possible involvement in HER2+ breast cancerBruna Karina Banin Hirata, Maria Angélica Ehara Watanabe, Roberta Losi Guembarovski et al.|Clinical and Experimental Medicine|2015Cited by 14